This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Stroma | |
|---|---|
| Name | Stroma |
| Location | Chloroplast, connective tissue, tumor microenvironment |
| Function | Supportive matrix, metabolic compartment, extracellular scaffold |
Stroma The stroma is a supportive tissue or matrix found in organs, cells, and tumors that provides structural framework and biochemical milieu for parenchymal elements. In biology and medicine the term denotes connective tissue in organs, the fluid-filled matrix of organelles such as chloroplasts, and the non-neoplastic compartment of neoplasms, each interacting with cells, vasculature, and signaling pathways. Classic examples span plant physiology, human histology, oncology, and regenerative biology, with roles conserved across species and research models.
Stromal architecture comprises cellular and extracellular components including fibroblasts, myofibroblasts, immune cells, endothelial cells, and an extracellular matrix of collagen, elastin, fibronectin, laminin, proteoglycans, and glycosaminoglycans, organized by signaling from developmental regulators such as transforming growth factor-beta and platelet-derived growth factor. In photosynthetic organelles the chloroplast compartment contains thylakoid membranes embedded within a protein- and enzyme-rich aqueous stroma that houses ribosomes, DNA, and enzymes for the Calvin–Benson cycle, interacting with photosystems I and II. Connective tissue stroma in organs such as the liver, kidney, and lung integrates with vascular networks influenced by angiogenic regulators including vascular endothelial growth factor and angiopoietins, and is remodeled by matrix metalloproteinases and tissue inhibitors of metalloproteinases under modulation by cytokines from cells like macrophages and lymphocytes.
Stromal compartments provide biomechanical support, mediate nutrient and gas exchange via capillary beds, and regulate parenchymal cell differentiation and function through paracrine signaling and extracellular matrix mechanics; examples include stem cell niches in bone marrow and epithelial–mesenchymal interactions during organogenesis mediated by fibroblast growth factors and Wnt signaling. In chloroplasts the stroma hosts the carbon fixation reactions catalyzed by Rubisco, regenerates ribulose-1,5-bisphosphate via the Calvin–Benson cycle, and coordinates with the thylakoid electron transport chain for ATP and NADPH utilization. Tumor stroma modulates cancer progression by influencing immune infiltration, metastatic potential, and therapeutic resistance through interactions with cancer-associated fibroblasts, tumor-associated macrophages, and the collagen-rich matrix that alters integrin signaling and mechanotransduction.
Stromal types include loose and dense connective tissue stroma found in organs such as the pancreas, spleen, and skin; mesenchymal stroma in bone marrow niches supporting hematopoietic stem cells; and the specialized stroma of endocrine organs like the thyroid and adrenal cortex. In plants the chloroplast stroma occupies the inner compartment surrounding thylakoids in mesophyll cells of leaves, where photosynthetic enzymes and plastid genomes are localized. Pathological stroma includes desmoplastic stroma in pancreatic ductal adenocarcinoma and fibrotic stroma in cirrhosis of the liver or idiopathic pulmonary fibrosis, often associated with altered composition and crosslinking of collagen types I and III.
Stromal development is governed by embryonic patterning cues such as Hedgehog, Notch, and T-box transcription factors that direct mesenchymal condensation, vascular invasion, and extracellular matrix deposition during organ morphogenesis. Postnatal remodeling relies on matrix metalloproteinase activity, lysyl oxidase–mediated collagen crosslinking, and cellular transdifferentiation events like epithelial–mesenchymal transition and pericyte recruitment during repair and fibrosis. In chloroplasts stroma composition adapts during photomorphogenesis and in response to light signaling pathways mediated by phytochromes and cryptochromes, altering enzyme abundance and stromal redox state to optimize the Calvin–Benson cycle.
Abnormal stromal responses contribute to diseases including cancer desmoplasia, organ fibrosis, chronic inflammatory disorders, and impaired wound healing; stromal signatures predict prognosis and therapeutic response in malignancies such as breast, prostate, and colorectal cancers, informing strategies involving stromal targeting with antifibrotic agents, immune checkpoint inhibitors, and antiangiogenic drugs. Fibrotic remodeling driven by TGF-β and persistent myofibroblast activation underlies conditions like liver cirrhosis and systemic sclerosis, while stromal alterations in the tumor microenvironment affect metastasis via epithelial–mesenchymal plasticity and matrix stiffness. In plant pathology, perturbation of chloroplast stroma metabolism affects crop yield and stress tolerance, relevant to breeding programs and genetic engineering efforts targeting photosynthetic efficiency.
Stromal research employs histology and immunohistochemistry using markers for fibroblasts, endothelial cells, and ECM components; single-cell RNA sequencing and spatial transcriptomics to resolve stromal heterogeneity; mass spectrometry proteomics and glycomics to profile matrix composition; and genetic models including conditional knockouts and lineage tracing to dissect developmental origins. In plant biology, chloroplast stroma is studied via chloroplast isolation, enzyme assays for Rubisco and sedoheptulose-1,7-bisphosphatase, fluorescence imaging of photosystems, and metabolic flux analysis with 13C labeling. Experimental tumor models use patient-derived xenografts, organoids co-cultured with stromal cells, and biomaterials-based scaffolds to interrogate stromal influence on therapy resistance and metastatic dissemination.